Artificial intelligence fears could lead to over-regulation

value alignment hands x
[A]s we begin to realise [artificial intelligence] opportunities, the potential risks increase: that AI will proliferate, uncontrolled and unregulated, in the hands of a few increasingly powerful technology firms, at the expense of jobs, equality and privacy. Already, mistakes over the sharing of patient records between DeepMind and the Royal Free Hospital in London have raised public concerns about technology firms being involved in digital healthcare.

Private companies will continue to use AI, unregulated, to improve the targeting of products. But in the public sector where there could be life-changing benefits, over-regulation will mean the opportunities will be lost. That is not to say that AI should be allowed to spread uncontrolled in the NHS. But it does emphasise why it’s so important to get this right. AI can only be introduced successfully in the NHS if the public, patients and healthcare professionals have confidence in the system, including clear oversight and accountability.


While there is a risk that a GM-style backlash could prevent the appropriate application of AI in healthcare, we should not give up hope. As the Information Commissioner has recently emphasised, it does not need to be a choice between privacy or innovation.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Why we can’t leave AI in the hands of Big Tech

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend